Top Anti Cancer Imported Medicine Drugs in India - Pharama Five
Help Desk :+916374297988

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org

Best Margenza (Margetuximab) Medicine in India

Buy Margenza (Margetuximab) Medicine in India

Margenza (Margetuximab)

Medicine name : Margenza

Generic name : Margetuximab

Manufactured By : Macrogenics

Indications : metastatic HER 2 +VE Breast cancer who hv received 2 prior anti HER 2 Regimens

Medicine Description : Margenza is an HER2-targeting monoclonal antibody for HER2-positive metastatic breast cancer. It enhances immune system activation against tumors. Given via IV infusion, it is used after prior HER2 therapies. Side effects include infusion reactions, heart problems, and low blood counts. Regular heart function tests help manage potential risks.

Product Introduction

Margenza (Margetuximab-cmkb) is a targeted anticancer medicine used in combination with chemotherapy to treat adults with HER2-positive metastatic breast cancer who have received two or more prior anti-HER2 treatment regimens, including at least one for metastatic disease. It is a monoclonal antibody that targets the HER2 protein on cancer cells, helping the immune system recognize and destroy these cells.

Margenza (Margetuximab-cmkb) is administered by a healthcare professional through an intravenous infusion. The dose and treatment schedule are determined by your doctor and are generally given in combination with an appropriate chemotherapy medicine. Your doctor may monitor you during and after the infusion for infusion-related reactions and may perform regular heart tests to monitor cardiac function.

Common side effects of Margenza may include fatigue, weakness, nausea, diarrhea, vomiting, constipation, headache, and infusion-related reactions. It may also cause serious heart problems or severe infusion reactions in some patients. Inform your doctor immediately if you experience chest pain, shortness of breath, swelling, severe dizziness, fever, chills, or other unusual symptoms. Before treatment, tell your doctor about any heart problems and all medicines, vitamins, herbal products, and supplements you are taking.

Uses Of Margenza (Margetuximab)

Treatment of HER2-Positive Metastatic Breast Cancer

Benefits Of Margenza

Margenza (Margetuximab-cmkb) is used in combination with chemotherapy to treat adults with HER2-positive metastatic breast cancer who have previously received two or more anti-HER2 treatment regimens. It targets the HER2 protein on cancer cells and helps the immune system recognize and destroy these abnormal cells. This can help reduce cancer cell growth and slow the progression of metastatic breast cancer.

Side Effects Of Margenza (Margetuximab)

Some side effects of Margenza (Margetuximab-cmkb) may improve as your body adjusts to the medicine. Consult your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Margenza (Margetuximab)

  • Fatigue
  • Weakness
  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Headache
  • Infusion-related reactions
  • Muscle or joint pain
  • Decreased appetite
How To Use Margenza

Margenza (Margetuximab-cmkb) is administered by a healthcare professional through an intravenous infusion, usually once every 3 weeks in combination with chemotherapy. The dose and treatment duration are determined by your doctor based on your condition and response to treatment. You will be monitored during and after the infusion for possible infusion-related reactions. Regular medical check-ups and heart-function tests may also be required during treatment.

How Margenza (Margetuximab) Works

Margenza (Margetuximab-cmkb) is a targeted monoclonal antibody that binds to the HER2 protein found on certain breast cancer cells. By attaching to HER2, it can block signals that promote cancer cell growth and also help activate the immune system to recognize and destroy HER2-positive cancer cells. This helps slow the growth and progression of HER2-positive metastatic breast cancer.

Safety Advice

AlcoholCONSULT YOUR DOCTOR

Consult your doctor before consuming alcohol during treatment with Margenza (Margetuximab-cmkb).

PregnancyCONSULT YOUR DOCTOR

Margenza may harm an unborn baby. Inform your doctor if you are pregnant or planning to become pregnant. Use effective contraception during treatment and for the recommended period after the final dose.

BreastfeedingCONSULT YOUR DOCTOR

Do not breastfeed during treatment with Margenza and for the recommended period after the final dose. Consult your doctor for guidance.

DrivingCONSULT YOUR DOCTOR

Margenza may cause fatigue, dizziness, or infusion-related reactions that can affect your ability to drive. Avoid driving if these symptoms occur.

KidneyCAUTION

Inform your doctor if you have kidney problems before starting treatment. Your doctor will determine whether any additional monitoring is needed.

LiverCAUTION

Tell your doctor if you have liver problems or are taking medicines that affect the liver. Your doctor may recommend appropriate monitoring during treatment.

Quick Tips
  • Attend all scheduled Margenza (Margetuximab-cmkb) infusions and follow your doctor's treatment schedule carefully.
  • Inform your healthcare team immediately if you experience fever, chills, dizziness, shortness of breath, or other symptoms during or after the infusion.
  • Attend regular heart-function tests as recommended by your doctor during treatment.
  • Contact your doctor promptly if you develop chest pain, unusual tiredness, swelling, or difficulty breathing.
  • Inform your doctor about all medicines, vitamins, herbal products, and dietary supplements you are taking to help prevent possible drug interactions.
  • Read More About - Margenza (Margetuximab) from Pharma Five.
Faq

General Question

Margenza (Margetuximab) is a prescription drug used to treat metastatic HER2-positive breast cancer in combination with chemotherapy.

Margenza is a monoclonal antibody that targets the HER2 protein on cancer cells, helping the immune system destroy them more effectively.

Doctors prescribe Margenza for adults with HER2-positive breast cancer who have previously received at least two anti-HER2 therapies.

Margenza is given as an intravenous (IV) infusion by a healthcare professional, typically once every three weeks.

Common side effects include fatigue, nausea, vomiting, diarrhea, fever, headache, and infusion-related reactions.

Yes, serious side effects may include heart problems, severe infusion reactions, or immune system-related issues. Consult your doctor if severe symptoms appear.

Margenza is taken as long as it remains effective and is well-tolerated or until your doctor advises stopping the treatment.

It is best to avoid alcohol while taking Margenza, as it may increase the risk of liver toxicity and worsen side effects.

No, Margenza may harm an unborn baby. Women should use effective contraception while on this medication and avoid pregnancy during treatment.

Yes, Margenza may interact with other drugs. Inform your doctor about all the medications, supplements, and herbal products you take.

Since Margenza is given as an IV infusion in a healthcare setting, your doctor will schedule the next dose if one is missed.

Margenza is an IV infusion and is not taken orally, so food does not affect its administration.

Regular heart monitoring, avoiding live vaccines, and informing your doctor about any allergies are important precautions while taking Margenza.

Margenza is stored in a medical facility under controlled conditions and should not be stored at home.

Margenza is available by prescription and is administered in hospitals or specialized infusion centers. Consult your doctor for treatment options. Pharma Five assists in its procurement.